Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
ALX 5407 is an inhibitor of glycine transporter 1 (GlyT1; IC50 = 3 nM).1 It is selective for GlyT1 over GlyT2 (IC50 = >10 µM), as well as over NMDA receptors and the inhibitory glycine receptor at 100 µM. ALX 5407 (10 mg/kg) increases prefrontal cortical levels of glycine in rats. It also reverses MK-801-induced persistent latent inhibition in a mouse model of schizophrenia.2
WARNING This product is not for human or veterinary use.
1. ALX 5407: A potent, selective inhibitor of the hGlyT1 glycine transporter. Mol. Pharmacol. 60(6), 1414-1420 (2001).
2. Modulators of the glycine site on NMDA receptors, ᴅ-